There is increasing evidence that abnormal DNA methylation of SNCA plays an essential role in a variety of tumors, such as cholangiocarcinoma [4], colonic adenocarcinoma [8], colorectal cancer [9], and non-Hodgkin lymphoma [14]. This evidence concerns the gene SNCA and colorectal cancer.